Medicare Expands Access to Weight Loss Drugs | Honolulu News

Medicare’s launching a bold new trial: starting July 2026, millions with qualifying health conditions may get life-changing weight-loss drugs like Wegovy and Zepbound for just $50 a month. Targeting those with high BMI or related health issues, this “GLP-1 Bridge” program could make these expensive treatments accessible to thousands — though it’s temporary and requires doctor approval. No deductible or out-of-pocket max hit, this move signals a major shift in how Medicare tackles weight-related health challenges. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/69532fcf5e09b1f4